MG
LH icon

Michael Gelband’s Labcorp LH Stock Holding History

Michael Gelband’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.08M Buy
+11,002
New +$2.89M 0.02% 652
2025
Q3 		– Sell
-93,407
Closed -$24.5M – 1801
2025
Q2 		$24.5M Buy
+93,407
New +$22.7M 0.22% 80
2024
Q2 		– Sell
-17,740
Closed -$3.88M – 1775
2024
Q1 		$3.88M Buy
+17,740
New +$3.91M 0.03% 470
2023
Q4 		– Sell
-75,384
Closed -$15.2M – 1793
2023
Q3 		$15.2M Buy
75,384
+73,924
+5,063% +$15.6M 0.14% 146
2023
Q2 		$303K Sell
1,460
-22,600
-94% -$4.38M ﹤0.01% 1536
2023
Q1 		$4.74M Buy
24,060
+10,752
+81% +$2.21M 0.04% 538
2022
Q4 		$2.69M Sell
13,308
-13,997
-51% -$2.74M 0.04% 531
2022
Q3 		$4.8M Buy
27,305
+4,269
+19% +$874K 0.06% 416
2022
Q2 		$4.64M Sell
23,036
-12,873
-36% -$2.74M 0.06% 436
2022
Q1 		$8.13M Buy
35,909
+19,584
+120% +$4.61M 0.1% 241
2021
Q4 		$4.41M Sell
16,325
-20,336
-55% -$5.03M 0.05% 480
2021
Q3 		$8.86M Buy
36,661
+19,416
+113% +$4.89M 0.12% 222
2021
Q2 		$4.09M Buy
+17,245
New +$3.93M 0.05% 421
2021
Q1 		– Sell
-13,293
Closed -$2.33M – 2378
2020
Q4 		$2.33M Buy
+13,293
New +$2.3M 0.02% 482
2020
Q3 		– Sell
-44,550
Closed -$6.36M – 2013
2020
Q2 		$6.36M Buy
+44,550
New +$6.16M 0.17% 117
2020
Q1 		– Sell
-4,464
Closed -$649K – 1389
2019
Q4 		$649K Sell
4,464
-7,898
-64% -$1.14M 0.01% 728
2019
Q3 		$1.78M Sell
12,362
-27,454
-69% -$4.01M 0.06% 264
2019
Q2 		$5.91M Buy
+39,816
New +$5.56M 0.24% 59

Other funds holding LH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Michael Gelband's LH Position: Q2 2026 in Review

Michael Gelband opened a new position in Labcorp (LH) in Q2 2026: 11,002 shares worth $3.08M. The stake represents 0.02% of the portfolio and ranks #652 among its holdings. This is a return to the name: Michael Gelband previously reported a position in LH as recently as Q2 2025.

Michael Gelband first reported a position in LH in Q2 2019 and has held it in 18 quarters since. The position peaked at $24.5M in Q2 2025. 1,051 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Michael Gelband held 11,002 shares of Labcorp worth $3.08M as of Q2 2026.
  • Labcorp was a new Michael Gelband position in Q2 2026.
  • Labcorp made up 0.02% of Michael Gelband's portfolio in Q2 2026, its #652 holding.
  • Michael Gelband first reported a position in Labcorp in Q2 2019 and has held it in 18 quarters since.
  • Michael Gelband's Labcorp position peaked at $24.5M in Q2 2025.
  • 1,051 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.